Seroepidemiological study of herpes simplex virus types 1 and 2 in Brazil, Estonia, India, Morocco, and Sri Lanka

Sexually Transmitted Infections

Volumn 79, Issue 4, 2003, Pages 286-290

  Cowan, Frances M ^a   French, R S ^a   Mayaud, P ^b   Gopal, R ^c   Robinson, N J ^d   Artimos De Oliveira, S ^e   Faillace, T ^f   Uuskula A ^g   Nygard Kibur M ^h   Ramalingam, S ⁱ   Sridharan, G ⁱ   El Aouad, R ^j   Alami, K ^k   Rbai, M ^l   Sunil Chandra, N P ^m   Brown, D W ^c  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c CENTRAL PUBLIC HEALTH LABORATORY   (United Kingdom)

^d GLAXOSMITHKLINE   (United Kingdom)

^e FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^f Policlinica Comunitaria S Rosa   (Brazil)

^g UNIVERSITY OF TARTU   (Estonia)

^h Institute of Experimental and Clinical Medicine Tallinn   (Estonia)

ⁱ CHRISTIAN MEDICAL COLLEGE   (India)

^j INSTITUT NATIONAL D HYGIÈNE   (Morocco)

^k Ministry of Health Morocco   (Morocco)

^l MILITARY HOSPITAL MOHAMMED V   (Morocco)

^m UNIVERSITY OF KELANIYA   (Sri Lanka)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HERPES SIMPLEX VACCINE; IMMUNOGLOBULIN G ANTIBODY; VIRUS ANTIBODY;

ADOLESCENT; ADULT; AGE; ALGORITHM; ARTICLE; BLOOD DONOR; BRAZIL; CHILD; CONTROLLED STUDY; ESTONIA; FEMALE; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HOSPITAL PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; INDIA; MAJOR CLINICAL STUDY; MALE; MOROCCO; PRENATAL CARE; SEROEPIDEMIOLOGY; SEROPREVALENCE; SERUM; SEX DIFFERENCE; SEXUALLY TRANSMITTED DISEASE; SOLDIER; SRI LANKA; VACCINATION;

ADOLESCENT; ADULT; BRAZIL; CHILD; CHILD, PRESCHOOL; ESTONIA; FEMALE; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HUMANS; INDIA; INFANT; INFANT, NEWBORN; MALE; MOROCCO; ODDS RATIO; PREVALENCE; SEROEPIDEMIOLOGIC STUDIES; SRI LANKA;

EID: 0041887086     PISSN: 13684973     EISSN: None     Source Type: Journal    
DOI: 10.1136/sti.79.4.286     Document Type: Article

References (19)

1. Nahmias AJ, Lee FK, Beckman-Nahmias S. Sero-epidemiological and sociological patterns of herpes simplex virus infection in the world. Scand J Infect Dis 1990;69:19-36.
2. Ross JDC, Smith IW, Elton RA. The epidemiology of herpes simplex types 1 and 2 infection of the genital tract in Edinburgh 1978-1991. Genitourin Med 1993;69:381-3.
3. Scoular A, Leask BGS, Carrington D. Changing trends in genital herpes due to Herpes simplex virus type 1 in Glasgow, 1985-88. Genitourin Med 1990;66:226-8.
4. Cowan FM, Johnson AM, Ashley R, et al. Antibody to herpes simplex virus type 2 as a serological marker of sexual lifestyle in populations. BMJ 1994;309:1325-9.
5. Obasi A, Mosha F, Quigley M, et al. Antibody to herpes simplex virus type 2 as a marker of sexual risk behaviour in rural Tanzania. J Infect Dis 1999;179:16-24.
6. Corey L, Handsfield HH. Genital herpes and public health - addressing a global problem. JAMA 2000;283:791-4.
7. Wasserheit J. Epidemiological synergy: interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases. Sex Transm Dis 1992;19:61-77.
8. Wald A, Link K. Risk of human immunodeficiency virus infection in herpes simplex virus type 2 seropositive persons: a meta-analysis. J Infect Dis 2002;185:45-52.
9. WHO and UNAIDS. Herpes simplex virus type 2: programmatic and research priorities in developing countries. Report of a WHO/UNAIDS/LSHTM workshop. London, 14-16 February 2001. WHO/HIV_AIDS/2001.05. 2001.
10. Corey L, Langenberg A, Ashley RL, et al. Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infections - 2 randomised controlled trials. JAMA 1999;282:331-40.
11. Stanberry L-R, Cunningham A-L, Mindel A, et al. Prospects for control of herpes simplex virus disease through immunization. Clin Infect Dis 2000;30:549-66.
12. UNAIDS. Report on the global HIV/AIDS epidemic: June 2000.
13. Prince HE, Ernst CE, Hogrefe WR. Evaluation of an enzyme immunoassay system for measuring herpes simplex virus (HSV) type 1-specific and HSV type 2- specific antibodies. J Clin Lab Anal 2000;14:13-16.
14. Gopal R, Gibbs T, Slomka MJ, et al. A monoclonal blocking EIA for herpes simplex virus type 2 antibody: validation for serological studies in Africa. J Virol Meth 2000;87:71-80.
15. Vyse A, Gay N, Slomka MJ, et al. The burden of infection with HSV-1 and HSV-2 in England and Wales: implications for the changing epidemiology of genital herpes. Sex Transm Infect 2000;76:183-7.
16. Mertz GJ, Schmidt O, Jourden JL, et al. Frequency of acquisition of fist-episode genital infection with Herpes simplex virus from symptomatic and asymptomatic source contracts. Sex Transm Dis 1985:33-9.
17. Brown ZA, Selke S, Zeh J, et al. The acquisition of herpes simplex virus during pregnancy. N Engl J Med 1997;337:509-15.
18. Langenberg A-G, Corey L, Ashley R-L, et al. A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group. N Engl J Med 1999;341:1432-8.
19. Dehne K-L, Pokrovskiy V, Kobyshcha Y, et al. Update on the epidemics of HIV and other sexually transmitted infections in the newly independent states of the former Soviet Union. AIDS 2000;14(Suppl 3):S75-84.